Physician profile
Eric Y Kim
NPI 1326576968
$1,604.92
in general payments reported to CMS, 2019-2025
16 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $11.51 · 2021: $203 · 2022: $225 · 2023: $201 · 2024: $517 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $880 · Entertainment: $13.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $879.98 |
| Entertainment | $13.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $465.48 | 2021-2025 | Clareon, Tryptyr, Eysuvis |
| Sun Pharmaceutical Industries INC. | $312.16 | 2021-2025 | Cequa, Xelpros |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $149.96 | 2019-2020 | |
| Sight Sciences, INC. | $144.10 | 2024 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $124.38 | 2022 | |
| Glaukos Corporation | $104.66 | 2019 | |
| Horizon Therapeutics Plc | $50.11 | 2023 | Tepezza |
| Boston Scientific Corporation | $42.91 | 2025 | Accolade Sr |
| Novartis Pharmaceuticals Corporation | $42.71 | 2019-2022 | |
| Rxsight INC | $37.66 | 2024 | Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Abbvie INC. | $34.89 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $31.24 | 2024 | Catalys System |
| Tarsus Pharmaceuticals, INC. | $29.43 | 2024 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $21.48 | 2021 | |
| Optos, INC. | $13.75 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.